top of page
Profile
Join date: Dec 4, 2023
Posts
Dec 6, 2023 ∙ 1 min
WE RECENTLY PUBLISHED A PEER-REVIEWED RESEARCH ARTICLE ON OUR RNA ANTICOAGULANT TECHNOLOGY
In the prestigious scientific journal, Advanced Materials (Impact Factor=27.4) Nucleic acid aptamers selected for thrombin binding have...
80
0
Dec 6, 2023 ∙ 1 min
WE HAVE RECEIVED A CHANCELLOR’S INNOVATION FUND (CIF) AWARD
The funding has allowed us to pursue pre-clinical evaluation of our anticoagulant and reversal agent. "As a land-grant university, our...
30
0
Dec 6, 2023 ∙ 1 min
A DRAFT OF OUR NEXT PAPER HAS BEEN POSTED TO BIORXIV.
The paper has also been submitted for peer-reviewed publication. Anticoagulants are commonly utilized during surgeries and to treat...
30
0
Cameron Feuerhelm
Admin
More actions
bottom of page